Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Korea SE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Kun Wha Pharmaceutical Co Ltd

+ Add to Watchlist

002250:KS

19,900 KRW 450 2.21%

As of 02:28:24 ET on 03/27/2015.

Snapshot for Kun Wha Pharmaceutical Co Ltd (002250)

Open: 20,300 Day's Range: 19,850 - 21,300 Volume: 111,618
Previous Close: 20,350 52wk Range: 12,100 - 25,500 1-Yr Rtn: -2.21%

Stock Chart for 002250

No chart data available.
  • 002250:KS 19,900
  • 1D
  • 1M
  • 1Y
20,350
Interactive 002250 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 002250

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. KOSPI -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M KRW) 235,972.65
Shares Outstanding (M) 11.86
30 Day Average Volume 111,045
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (KRW) -
Dividend Ex-Date 12/27/2013
5 Year Dividend Growth -
Next Earnings Announcement 03/03/2016
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 002250

No data available

Company Profile & Key Executives for 002250

Kun Wha Pharmaceutical Co., Ltd. is a pharmaceutical company. The Company researches, develops, manufactures, and markets drugs such as anti-inflammatory agents, antibiotics, antifungal agents, and remedies for the alimentary and cardiovascular systems.

Lee Joo-HyungCEO/Rep DirectorKim Dae-HwanSenior Managing Director
Lee Bok-SangSenior Managing DirectorKim Choong-RyulSenior Managing Director
More Company Profile & Key Executives for 002250

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil